Long-term Risk of Serious Infections and Mortality Among Patients Surviving Drug Use-Associated Infective Endocarditis.
| dc.contributor.author | Figgatt, Mary C | |
| dc.contributor.author | Rosen, David L | |
| dc.contributor.author | Chu, Vivian H | |
| dc.contributor.author | Wu, Li-Tzy | |
| dc.contributor.author | Schranz, Asher J | |
| dc.date.accessioned | 2024-11-21T15:19:15Z | |
| dc.date.available | 2024-11-21T15:19:15Z | |
| dc.date.issued | 2024-07 | |
| dc.description.abstract | Among a statewide cohort of 1874 patients surviving hospitalization for drug use-associated endocarditis during 2017-2020, the 3-year risk of death or future hospitalization was 38% (16% for death before later infection, 14% for recurrent endocarditis, 14% for soft tissue, 9% for bacteremia, 5% for bone/joint, and 4% for spinal infections). | |
| dc.identifier | 7655431 | |
| dc.identifier.issn | 1058-4838 | |
| dc.identifier.issn | 1537-6591 | |
| dc.identifier.uri | ||
| dc.language | eng | |
| dc.publisher | Oxford University Press (OUP) | |
| dc.relation.ispartof | Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | |
| dc.relation.isversionof | 10.1093/cid/ciae214 | |
| dc.rights.uri | ||
| dc.subject | Humans | |
| dc.subject | Bacteremia | |
| dc.subject | Endocarditis, Bacterial | |
| dc.subject | Endocarditis | |
| dc.subject | Substance-Related Disorders | |
| dc.subject | Hospitalization | |
| dc.subject | Risk Factors | |
| dc.subject | Cohort Studies | |
| dc.subject | Adult | |
| dc.subject | Aged | |
| dc.subject | Middle Aged | |
| dc.subject | Female | |
| dc.subject | Male | |
| dc.title | Long-term Risk of Serious Infections and Mortality Among Patients Surviving Drug Use-Associated Infective Endocarditis. | |
| dc.type | Journal article | |
| duke.contributor.orcid | Wu, Li-Tzy|0000-0002-5909-2259 | |
| pubs.begin-page | 56 | |
| pubs.end-page | 59 | |
| pubs.issue | 1 | |
| pubs.organisational-group | Duke | |
| pubs.organisational-group | Sanford School of Public Policy | |
| pubs.organisational-group | School of Medicine | |
| pubs.organisational-group | Clinical Science Departments | |
| pubs.organisational-group | Institutes and Centers | |
| pubs.organisational-group | Medicine | |
| pubs.organisational-group | Psychiatry & Behavioral Sciences | |
| pubs.organisational-group | Medicine, General Internal Medicine | |
| pubs.organisational-group | Medicine, Infectious Diseases | |
| pubs.organisational-group | Duke Clinical Research Institute | |
| pubs.organisational-group | University Institutes and Centers | |
| pubs.organisational-group | Duke Institute for Brain Sciences | |
| pubs.organisational-group | Psychiatry, Child & Family Mental Health & Community Psychiatry | |
| pubs.organisational-group | Center for Child and Family Policy | |
| pubs.publication-status | Published | |
| pubs.volume | 79 |
Files
Original bundle
- Name:
- Figgatt..Wu.2024 risk of infections-mortality in patients w drug-associated endocarditis.pdf
- Size:
- 350.79 KB
- Format:
- Adobe Portable Document Format
- Description:
- Published version